Podcast Episodes

Back to Search
RELX Stock: A Great Compounder Fell 38% on AI Fear — and Just Accelerated. Why We Say BUY (H1 2026)

RELX PLC (RELX) H1 2026 — RELX PLC (NYSE: RELX), the information-and-analytics owner of LexisNexis, Elsevier and its Risk data business, reported str…

3 months ago

Short Long
View Episode
Graco Stock: A Record Quarter, and the Stock Went Nowhere. Why We Say HOLD (GGG Q2 2026)

Graco Inc. (GGG) Q2 2026 — Graco (GGG), the quiet niche leader in precision fluid-handling equipment, reported record Q2 2026 sales and operating ear…

3 months ago

Short Long
View Episode
Canadian National Railway Stock: It Beat and Raised Guidance — Why We Still Say HOLD (CNI Q2 2026)

Canadian National Railway (CNI) Q2 2026 — Canadian National Railway (CNI on the NYSE, CNR on the TSX) — the only railroad whose network reaches three…

3 months ago

Short Long
View Episode
World Kinect Stock: A Record 72% Beat Sent It Soaring — Why We Say HOLD (WKC)

World Kinect (WKC) Q2 2026 — World Kinect (WKC), the global fuel-logistics distributor formerly known as World Fuel Services, reported a record Q2 20…

3 months ago

Short Long
View Episode
Verizon Stock: Beat, RAISED Guidance, 6% Yield — Why We Say BUY While Wall Street Waits (VZ)

Verizon Communications (VZ) Q2 2026 — Verizon Communications (VZ) reported a strong Q2 2026: adjusted EPS of $1.30 beat the ~$1.27 estimate (+6.6% Yo…

3 months ago

Short Long
View Episode
NextEra Energy Stock: It Beat Earnings and Is Buying Dominion — So Why We Say HOLD (NEE Q2 2026)

NextEra Energy (NEE) Q2 2026 — NextEra Energy (NEE), the largest U.S. electric utility and the world's biggest generator of wind and solar, reported …

3 months ago

Short Long
View Episode
Vita Coco Stock: It CRUSHED Earnings and RAISED Guidance — So Why We Say HOLD

The Vita Coco Company (COCO) Q2 2026 — The Vita Coco Company (COCO), the #1 coconut-water brand, reported a blowout Q2 2026: EPS of $0.82 crushed the…

3 months, 1 week ago

Short Long
View Episode
Quest Diagnostics Stock (DGX): It Beat, RAISED Guidance, and Broke Out — Why We Say BUY

Quest Diagnostics (DGX) Q2 2026 — Quest Diagnostics (DGX), one of the two national giants of U.S. lab testing, reported a strong Q2 2026: adjusted EP…

3 months, 1 week ago

Short Long
View Episode
HCA Healthcare Stock: It Beat Q2 but CUT Its Guidance — So Why We Say BUY

HCA Healthcare (HCA) Q2 2026 — HCA Healthcare (HCA), the largest for-profit hospital operator in the U.S., delivered a headline-beating Q2 2026 — the…

3 months, 1 week ago

Short Long
View Episode
TotalEnergies Stock: $6B Profit, 7.5% Yield, ~9x Earnings — So Why We Say BUY

TotalEnergies SE (TTE) Q2 2026 — TotalEnergies (TTE), the French supermajor and NYSE-listed ADR (1 ADR = 1 ordinary share), reported a blowout Q2 202…

3 months, 1 week ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us